New Century Financial Group LLC Buys Shares of 243 Axon Enterprise, Inc $AXON

New Century Financial Group LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 243 shares of the biotechnology company’s stock, valued at approximately $201,000.

A number of other institutional investors have also made changes to their positions in the business. Ameritas Advisory Services LLC bought a new position in shares of Axon Enterprise in the second quarter worth about $162,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in shares of Axon Enterprise by 19.1% in the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 1,387 shares of the biotechnology company’s stock worth $1,148,000 after purchasing an additional 222 shares during the period. Yeomans Consulting Group Inc. bought a new position in shares of Axon Enterprise in the second quarter worth about $675,000. River Street Advisors LLC bought a new position in shares of Axon Enterprise in the second quarter worth about $269,000. Finally, Hilltop National Bank bought a new position in shares of Axon Enterprise in the second quarter worth about $345,000. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of Axon Enterprise in a research report on Saturday, September 27th. JPMorgan Chase & Co. lifted their target price on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research report on Thursday, July 17th. UBS Group reissued a “neutral” rating and set a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Finally, Bank of America lifted their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $841.64.

Axon Enterprise Stock Down 0.7%

NASDAQ AXON opened at $715.51 on Friday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock’s 50 day moving average is $757.79 and its two-hundred day moving average is $707.36. The company has a market capitalization of $56.17 billion, a price-to-earnings ratio of 176.67, a PEG ratio of 27.98 and a beta of 1.41. Axon Enterprise, Inc has a 1-year low of $413.68 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, President Joshua Isner sold 15,919 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares of the company’s stock, valued at $177,892,712.54. The trade was a 6.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $831.29, for a total value of $8,312,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,053,982 shares in the company, valued at $2,538,744,696.78. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 49,932 shares of company stock worth $37,978,216 over the last ninety days. 4.40% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.